Breakthrough Cancer Therapy for Dire Cases Gets FDA Approval

U.S. regulators approved a revolutionary fresh cancer treatment from Novartis AG on Wednesday, the very first in a group of coming therapies that suggest breakthrough cures for dire cases as well as stratospheric costs.

Known as CAR-T therapy, the treatment involves extracting a patient’s immune system cells and modifying them to attack aggressive blood cancers. Continue reading Breakthrough Cancer Therapy for Dire Cases Gets FDA Approval